Leaders in the transplantation field and well-regarded ERS Officers, Michael Perch and Federica Meloni, join Dorina Esendagli in a podcast focusing on the latest Monograph: Lung Transplantation. Covering the formidable topics of immunosuppressive treatment and post-transplant care, it is clear that both the podcast and book are hugely relevant to the transplant specialist. However, Michael and Federica explain that the book is also aimed at specialists in other areas of pneumology, as well as general physicians from beyond the respiratory field. Broadening understanding about this challenging area is essential if we are to improve prognosis and widen donor availability.

As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and Deputy Chief Editor Don Sin for their end-of-year roundup of their highlights from the ERJ in 2024.

As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Sanjay Chotirmall about articles published from in the current issue.

"There isn't, and it is unlikely there ever will be, a single approach to long COVID. It's very much about personalised medicine."

James Chalmers steps away from the ERJ briefly to discuss the recent Monograph on "COVID-19: An Update", which he co-Guest Edited with Catia Cilloniz and Bin Cao. Dorina Esendagli (the Monograph's Early Career Member representative) talks to James about diagnostic tools, diversity in clinical presentation, approaches to treatment, vaccine boosters for new variants, the treatable traits concept and, importantly, the ongoing problem of long COVID.

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews associate editor Marius Hoeper and Kelly Chin (UT Southwestern Medical Center, Dallas, TX, USA) about articles published from the World Symposium on Pulmonary Hypertension.

"We need to recognise that having an adolescent-specific service will ultimately provide the foundations for lifelong healthcare"

Alexandra M. Nanzer joins Dorina Esendagli (the Monograph's Early Career Member representative) to talk about her Monograph, "The Transition of Respiratory Care: from Child to Adult". Their awareness-raising discussion covers areas such as: ensuring continuity of care throughout transition; the challenges faced during the process; the requirements of the patient; and the areas on which future research and funding should focus.

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and Deputy Chief Editor Don Sin interview section editor Marc Humbert and Pamela McShane (University of Texas, Tyler, TX, USA) about articles presented at the ERS Congress.

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marianne Baastrup Soendergaard (Department of Respiratory Medicine, Copenhagen University Hospital – Bispebjerg, Copenhagen, Denmark) about the OPTIMAL study: an open-label randomised controlled trial of titration of anti-interleukin-5 biologic therapy in severe asthma.

As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Rachel Bowsher (Toxicology Department, UK Health Security Agency, Chilton, and Pharmacology Section, St George’s University of London, London, UK) about a study that uses novel methodology to demonstrate that smoking and vaping alter genes related to mechanisms of SARS-CoV-2 susceptibility and severity.

As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Steven D. Nathan (Inova Fairfax Hospital, Falls Church, VA, USA) about the PERFECT study, which showed that inhaled treprostinil does not demonstrate a positive risk–benefit ratio in favour of treatment in pulmonary hypertension associated with COPD.